pembrolizumab
merck
['mibc', 'pembro', 'pure-01']
biology and performance of pre- &amp; post-pembro vi-rads to predict the pathol resp in mibc pure-01, 110 pts had mri (n=220 mris) pre-pembro: 19.1% vi-rads 0, 30.9% 1-3, 50.0% 4-5 17.4% downstaging from vi-rads 4-5 to 0-3 post-pembro #asco23 
Uro Onc @GACancerCenter | Assoc Prof, Resident PD, and Ronald W. Lewis, MD Chair of Uro Educ @mcg_urology | #mentalhealth research | @urotoday Contributor